multiple sclerosis (MS)

Kristin O’Grady, PhD, in the 3T MRI suite at Vanderbilt University Hospital. (photo by Susan Urmy)

Kristin O’Grady receives $2.4 million for multiple sclerosis imaging studies

The awards will support O’Grady’s application of structural and functional magnetic resonance imaging to better understand symptoms and track MS progression in the lower spinal cord.

Specialty pharmacists help reduce MS relapse risk

Just one-third of patients with relapsing multiple sclerosis remain on disease-modifying therapy, and specialty pharmacists are in a unique position to help coordinate therapy discontinuation or change and reduce the risk of relapse.

Multiple sclerosis, lung cancer, and 50 marathons: Aaron Hawkins about to reach amazing milestone

“He has been a blessing and role model for so many,” his doctor Jonathan Nesbitt says.

Ayaka Sugiura and Jeff Rathmell, PhD, are studying a metabolic enzyme involved in T cell function that may offer a new target for anti-inflammatory therapeutics.

CRISPR screen identifies new anti-inflammatory drug target

A novel CRISPR screen developed by Vanderbilt researchers identified a promising new target for anti-inflammatory therapeutics.

After being diagnosed with MS, Jonathan Davidson decided to take up running. He just completed his 50th marathon — one in each of the 50 states.

Holding his infant daughter led him to vow to take care of himself so he could coach her soccer team and, someday, walk her down the aisle.

Vanderbilt Multiple Sclerosis Center opens relapse clinic

The Vanderbilt Multiple Sclerosis Center has opened a relapse clinic that offers expedited access for patients experiencing disease flare-ups.

1 2